Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F B Palumbo

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Pharmaceutical Research|October 1, 1990
Treating seriously ill patients with experimental drugsF B Palumbo
American Pharmacy|September 1, 1994
Pharmaceutical care and payment reformF B Palumbo
American Pharmacy|April 1, 1991
The impact of the Rx to OTC switch on practicing pharmacistsF B Palumbo
Pharmaceutical Research|January 1, 1990
Reimbursement for drugs under third-party programsF B Palumbo
Food and Drug Law Journal|April 12, 2002
The role of the state as a drug purchaserF B Palumbo
Pharmacoeconomics|June 3, 1999
The effect of managed care on prescription drug costs and benefitsA Lyles, F B Palumbo
Journal of Pharmaceutical Marketing & Management|December 11, 1987
The "treatment IND (investigational new drugs)": public policy considerationsC Roberts, F B Palumbo
The New England Journal of Medicine|February 6, 1997
Quality-of-care data from managed-care organizationsF B Palumbo, C D Mullins
American Journal of Pharmaceutical Education|November 9, 1975
A realistic appraisal of the potential contribution of the social and behavioral sciences to professional education in pharmacy: economic aspectsD A Knapp, F B Palumbo
Journal of the American Pharmaceutical Association|April 1, 1977
Dollar costs of conducting drug use reviewD A Knapp, F B Palumbo
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Pharmaceutical Research|October 1, 1990
Treating seriously ill patients with experimental drugsF B Palumbo
American Pharmacy|September 1, 1994
Pharmaceutical care and payment reformF B Palumbo
American Pharmacy|April 1, 1991
The impact of the Rx to OTC switch on practicing pharmacistsF B Palumbo
Pharmaceutical Research|January 1, 1990
Reimbursement for drugs under third-party programsF B Palumbo
Food and Drug Law Journal|April 12, 2002
The role of the state as a drug purchaserF B Palumbo
Pharmacoeconomics|June 3, 1999
The effect of managed care on prescription drug costs and benefitsA Lyles, F B Palumbo
Journal of Pharmaceutical Marketing & Management|December 11, 1987
The "treatment IND (investigational new drugs)": public policy considerationsC Roberts, F B Palumbo
The New England Journal of Medicine|February 6, 1997
Quality-of-care data from managed-care organizationsF B Palumbo, C D Mullins
American Journal of Pharmaceutical Education|November 9, 1975
A realistic appraisal of the potential contribution of the social and behavioral sciences to professional education in pharmacy: economic aspectsD A Knapp, F B Palumbo
Journal of the American Pharmaceutical Association|April 1, 1977
Dollar costs of conducting drug use reviewD A Knapp, F B Palumbo
Pageof 2